Illicit Fentanyl in the Prenatal Period: A Significant Emerging Risk for Neonatal Opioid Withdrawal Syndrome
American Journal of Perinatology · 01.05.2025 · 42 (07) · 891-898
DOI: 10.1055/a-2437-0828 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2025. Verfasst von Divya Rana und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neonatology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee. Hauptthemen laut MEDLINE: Fentanyl, Neonatal Abstinence Syndrome, Opioid-Related Disorders, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
This study aimed to evaluate the impact of in-utero illicit fentanyl exposure on neonatal outcomes, including neonatal opioid withdrawal syndrome (NOWS), length of stay (LOS), and treatment requirements. This study was conducted from March 2020 to December 2022, and focused on neonates born to mothers with opioid use or opioid use disorder (OUD). Maternal opioid use was identified through self-report or umbilical cord tissue (UCT) testing. Severe NOWS was defined as cases requiring pharmacological treatment. Statistical analyses included univariate comparisons, logistic regression, and generalized linear models to assess the associations between fentanyl exposure and neonatal outcomes. Forty-seven percent (75/159) of infants had in-utero fentanyl exposure. Fentanyl-positive mothers were older, 31 ± 5 years, compared to non-fentanyl mothers, 29 ± 5, p = 0.01. They were also less likely to receive prenatal care (p < 0.01) and had a higher number of polysubstance used, 5 ± 1 compared to non-fentanyl mothers, 3 ± 1, p < 0.01. Overall, infants exposed to fentanyl had a higher incidence of severe NOWS (odds ratio = 5.8, 95% confidence interval [CI]: 2.49–12.95, p < 0.01) and required earlier NOWS treatment initiation, 1 ± 1 day compared to non-exposed infants 3 ± 2 days, p < 0.01. In adjusted analysis, fentanyl exposure was associated with a nearly three-fold increased risk of NOWS (Mantel–Haenszel combined relative risk = 2.98, 95% CI: 1.94–4.57). Furthermore, fentanyl exposure led to longer LOS, with a 40% increase for preterm neonates (p < 0.01) and a 63% increase for full-term neonates (p < 0.01). Additionally, there was a significant correlation between log fentanyl concentration in umbilical cord tissue and cumulative morphine dose required for NOWS treatment, p = 0.001. Prenatal illicit fentanyl exposure is an independent and strong risk factor for severe NOWS presentation in newborns requiring extended hospital stays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neonatology, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
- Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, Tennessee.
- Department of Physiology, University of Tennessee Health Science Center, Memphis, Tennessee.
ORCID-Profile: Divya Rana
Zitieren
APA
Rana, D., Gaston, K. P., DeBaer, L., & Pourcyrous, M. (2025). Illicit Fentanyl in the Prenatal Period: A Significant Emerging Risk for Neonatal Opioid Withdrawal Syndrome. American Journal of Perinatology, 42(07), 891-898. https://doi.org/10.1055/a-2437-0828
Vancouver
Rana D, Gaston KP, DeBaer L, Pourcyrous M. Illicit Fentanyl in the Prenatal Period: A Significant Emerging Risk for Neonatal Opioid Withdrawal Syndrome. American Journal of Perinatology. 2025;42(07):891-898. doi:10.1055/a-2437-0828
BibTeX
@article{Rana2025,
author = {Rana, Divya and Gaston, Kan P and DeBaer, Linda and Pourcyrous, Massroor},
title = {Illicit Fentanyl in the Prenatal Period: A Significant Emerging Risk for Neonatal Opioid Withdrawal Syndrome},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {07},
pages = {891--898},
doi = {10.1055/a-2437-0828}
}
EUVIMED